Company intelligence / Profile preview

Selkirk Pharma

Spokane, Washington, United States

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Selkirk Pharma is a US-based contract manufacturer specializing in sterile fill/finish of injectable pharmaceuticals, with GMP operations commencing in late 2024 at a state-of-the-art facility designed for both clinical and commercial drug production. They offer advanced technology for high-yield manufacturing of both biologics and small molecules, but do not develop proprietary therapeutics.

Modalities: Small moleculeBiologicInjectable drug product
Industry: Contract Manufacturing Organization

Partnerships

Embree Capital Markets Group (facility financing)Bausch & Strobel (equipment)SKAN (aseptic technology)

Beyond the preview

Go deeper on Selkirk Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selkirk Pharma.

Explore the full profile